Update: Interim guidance for health care providers caring for pregnant women with possible Zika virus exposure — United States (including U.S. territories), July 2017

Morbidity and Mortality Weekly Report

Volumn 66, Issue 29, 2017, Pages 781-793

  Oduyebo, Titilope ^a   Polen, Kara D ^a   Walke, Henry T ^a   Reagan Steiner, Sarah ^a   Lathrop, Eva ^a   Rabe, Ingrid B ^a   Kuhnert Tallman, Wendi L ^a   Martin, Stacey W ^a   Walker, Allison T ^a   Gregory, Christopher J ^a   Ades, Edwin W ^a   Carroll, Darin S ^a   Rivera, Maria ^a   Perez Padilla, Janice ^a   Gould, Carolyn ^a   Nemhauser, Jeffrey B ^a   Beard, C Ben ^a   Harcourt, Jennifer L ^a   Viens, Laura ^a   Johansson, Michael ^a   Ellington, Sascha R ^a   Petersen, Emily ^a   Smith, Laura A ^a   Reichard, Jessica ^a   Munoz Jordan, Jorge ^a   Beach, Michael J ^a   Rose, Dale A ^a   Barzilay, Ezra ^a   Noonan Smith, Michelle ^a   Jamieson, Denise J ^a   Zaki, Sherif R ^a   Petersen, Lyle R ^a   Honein, Margaret A ^a   Meaney Delman, Dana ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HEALTH CARE PERSONNEL; HUMAN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUBLIC HEALTH SERVICE; UNITED STATES; ZIKA VIRUS INFECTION;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HEALTH PERSONNEL; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES; ZIKA VIRUS INFECTION;

EID: 85026635616     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6629e1     Document Type: Article

References (35)

1. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232–9. https://doi.org/10.3201/eid1408.080287
2. Pan American Health Organization. Regional Zika epidemiological update (Americas) May 25, 2017. Washington, DC: Pan American Health Organization. http://www.paho.org/hq/index.php?option=com_content&view=article&id=11599&Itemid=41691&lang=en
3. Hancock WT, Soeters HM, Hills SL, et al. Establishing a timeline to discontinue routine testing of asymptomatic pregnant women for Zika virus infection—American Samoa, 2016–2017. MMWR Morb Mortal Wkly Rep 2017;66:299–301. https://doi.org/10.15585/mmwr.mm6611a5
4. World Health Organization. Zika virus country classification scheme: interim guidance. Geneva, Switzerland: World Health Organization, 2017. http://www.who.int/csr/resources/publications/zika/classification/en/
5. Rabe IB, Staples JE, Villanueva J, et al.; MTS. MTS. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 2016;65:543–6. https://doi.org/10.15585/mmwr.mm6521e1
6. Woods CR. False-positive results for immunoglobulin M serologic results: explanations and examples. J Pediatric Infect Dis Soc 2013;2:87–90. https://doi.org/10.1093/jpids/pis133
7. Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014;19:20761. https://doi.org/10.2807/1560-7917.ES2014.19.14.20761
8. Paz-Bailey G, Rosenberg ES, Doyle K, et al. Persistence of Zika virus in body fluids —preliminary report. N Engl J Med 2017;NEJMoa1613108. https://doi.org/10.1056/NEJMoa1613108
9. Bocanegra C, Sulleiro E, Soriano-Arandes A, et al. Zika virus infection in pregnant women in Barcelona, Spain. Clin Microbiol Infect 2016;22:648–50. https://doi.org/10.1016/j.cmi.2016.03.025
10. Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016;374:2142–51. https://doi.org/10.1056/NEJMoa1601824
11. Meaney-Delman D, Oduyebo T, Polen KN, et al.; U.S. Zika Pregnancy Registry Prolonged Viremia Working Group. Prolonged detection of Zika virus RNA in pregnant women. Obstet Gynecol 2016;128:724–30. https://doi.org/10.1097/AOG.0000000000001625
12. Pacheco O, Beltrán M, Nelson CA, et al. Zika Virus disease in Colombia—preliminary report. N Engl J Med 2016;NEJMoa1604037. https://doi.org/10.1056/NEJMoa1604037
13. Schaub B, Vouga M, Najioullah F, et al. Analysis of blood from Zika virus-infected fetuses: a prospective case series. Lancet Infect Dis 2017;17:520–7. https://doi.org/10.1016/S1473-3099(17)30102-0
14. St George K, Sohi IS, Dufort EM, et al. Zika virus testing considerations: lessons learned from the first 80 real-time reverse transcription- PCR-positive cases diagnosed in New York State. J Clin Microbiol 2017;55:535–44. https://doi.org/10.1128/JCM.01232-16
15. Suy A, Sulleiro E, Rodó C, et al. Prolonged Zika virus viremia during pregnancy. N Engl J Med 2016;375:2611–3. https://doi.org/10.1056/NEJMc1607580
16. Bingham AM, Cone M, Mock V, et al. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease—Florida, 2016. MMWR Morb Mortal Wkly Rep 2016;65:475–8. https://doi.org/10.15585/mmwr.mm6518e2
17. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003;9:376–9. https://doi.org/10.3201/eid0903.020531
18. CDC. Prolonged IgM antibody response in people infected with Zika virus: implications for interpreting serologic testing results for pregnant women. Atlanta, GA: US Department of Health and Human Services, CDC; 2017.
19. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 1981;59:895–900.
20. Okuno Y, Fukunaga T, Tadano M, et al. Serological studies on volunteers inoculated experimentally with a dengue virus strain in 1943. Biken J 1983;26:161–3.
21. Calisher CH, Karabatsos N, Dalrymple JM, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989;70:37–43. https://doi.org/10.1099/0022-1317-70-1-37
22. Halstead SB, Rojanasuphot S, Sangkawibha N. Original antigenic sin in dengue. Am J Trop Med Hyg 1983;32:154–6. https://doi.org/10.4269/ajtmh.1983.32.154
23. Johnson BW, Kosoy O, Martin DA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 2005;5:137–45. https://doi.org/10.1089/vbz.2005.5.137
24. Ikejezie J, Shapiro CN, Kim J, et al. Zika virus transmission—Region of the Americas, May 15, 2015–December 15, 2016. MMWR Morb Mortal Wkly Rep 2017;66:329–34. https://doi.org/10.15585/mmwr.mm6612a4
25. Massad E, Behrens BC, Coutinho FA, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malar J 2011;10:130. https://doi.org/10.1186/1475-2875-10-130
26. Pinsent A, Read JM, Griffin JT, et al. Risk factors for UK Plasmodium falciparum cases. Malar J 2014;13:298. https://doi.org/10.1186/1475-2875-13-298
27. Williamson PC, Linnen JM, Kessler DA, et al. First cases of Zika virusinfected US blood donors outside states with areas of active transmission. Transfusion 2017;57:770–8. https://doi.org/10.1111/trf.14041
28. Shapiro-Mendoza CK, Rice ME, Galang RR, et al.; Zika Pregnancy and Infant Registries Working Group. Pregnancy outcomes after maternal Zika virus infection during pregnancy—U.S. territories, January 1, 2016–April 25, 2017. MMWR Morb Mortal Wkly Rep 2017;66:615–21. https://doi.org/10.15585/mmwr.mm6623e1
29. Reynolds MR, Jones AM, Petersen EE, et al.; U.S. Zika Pregnancy Registry Collaboration. Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure—U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep 2017;66:366–73. https://doi.org/10.15585/mmwr.mm6613e1
30. Petersen EE, Meaney-Delman D, Neblett-Fanfair R, et al. Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for persons with possible Zika virus exposure—United States, September 2016. MMWR Morb Mortal Wkly Rep 2016;65:1077–81. https://doi.org/10.15585/mmwr.mm6539e1
31. Parra-Saavedra M, Reefhuis J, Piraquive JP, et al. Serial head and brain imaging of 17 fetuses with confirmed Zika virus infection in Colombia, South America. Obstet Gynecol 2017;130:207–12. https://doi.org/10.1097/AOG.0000000000002105
32. Bhatnagar J, Rabeneck DB, Martines RB, et al. Zika virus RNA replication and persistence in brain and placental tissue. Emerg Infect Dis 2017;23:405–14. https://doi.org/10.3201/eid2303.161499
33. Reagan-Steiner S, Simeone R, Simon E, et al.; Zika Virus Response Epidemiology and Surveillance Task Force Pathology Team. Evaluation of placental and fetal tissue specimens for Zika virus infection—50 states and District of Columbia, January–December, 2016. MMWR Morb Mortal Wkly Rep 2017;66:636–43. https://doi.org/10.15585/mmwr.mm6624a3
34. Russell K, Oliver SE, Lewis L, et al.; Contributors. Contributors. Update: interim guidance for the evaluation and management of infants with possible congenital Zika virus infection—United States, August 2016. MMWR Morb Mortal Wkly Rep 2016;65:870–8. https://doi.org/10.15585/mmwr.mm6533e2
35. Oduyebo T, Igbinosa I, Petersen EE, et al. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure—United States, July 2016. MMWR Morb Mortal Wkly Rep 2016;65:739–44. https://doi.org/10.15585/mmwr.mm6529e1